Seroprevalence of Hepatitis C Virus and Factors Associated with It in Armenia, 2021
Viruses · 2024
DOI: 10.3390/v16091446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Anahit Demirchyan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Turpanjian College of Health Sciences, American University of Armenia, 40 Marshal Baghramyan Ave., Yerevan 0019, Armenia. Hauptthemen laut MEDLINE: Hepacivirus, Hepatitis C Antibodies, Genotype, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, WHO Regional Office for Europe.
Abstract (Originalsprache)
Hepatitis C virus (HCV) infection is among the leading causes of cirrhosis and hepatocellular carcinoma. Knowledge of its prevalence and risk factors can help to effectively fight the virus. This study was the first to investigate the seroprevalence of HCV, its genotypes, and factors associated with it among the general adult population of Armenia selected countrywide via cluster sampling. Anti-HCV antibodies were detected using third-generation immunoassay. Polymerase chain reaction and genotyping was performed among anti-HCV-positive individuals. Shortly after testing, the participants underwent a telephone survey. Logistic regression models were fitted to identify factors associated with anti-HCV antibody positivity and chronic HCV infection. The prevalence of anti-HCV antibodies among 3831 tested individuals was 2% (99% CI 1.4, 2.5), and chronic HCV infection was 0.7% (99% CI 0.4, 1.0), with genotypes 3 and 2 being the most common. The risk factors for chronic HCV infection included self-reported chronic liver disease (95% CI 1.47, 15.28), having tattoos (95% CI 1.34, 10.94), ever smoking (95% CI 1.16, 9.18), and testing positive for hepatitis B virus core antibody (95% CI 1.02, 7.17). These risk factors demonstrate that there could be room for strengthening infection control measures to prevent the transmission of HCV in Armenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Turpanjian College of Health Sciences, American University of Armenia, 40 Marshal Baghramyan Ave., Yerevan 0019, Armenia.
- Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, 1211 Geneva, Switzerland.
- National Institute of Health, Ministry of Health, Republic of Armenia, Yerevan 0051, Armenia.
- World Health Organization Country Office in Armenia, Yerevan 0015, Armenia.
ORCID-Profile: Serine Sahakyan, Lusine Musheghyan, Varduhi Petrosyan
Förderung
- World Health Organization
- WHO Regional Office for Europe
Zitieren
APA
Demirchyan, A., Mozalevskis, A., Sahakyan, S., Musheghyan, L., Aslanyan, L., Muradyan, D., Sargsyants, N., Ghukasyan, G., & Petrosyan, V. (2024). Seroprevalence of Hepatitis C Virus and Factors Associated with It in Armenia, 2021. Viruses. https://doi.org/10.3390/v16091446
Vancouver
Demirchyan A, Mozalevskis A, Sahakyan S, Musheghyan L, Aslanyan L, Muradyan D, et al. Seroprevalence of Hepatitis C Virus and Factors Associated with It in Armenia, 2021. Viruses. 2024. doi:10.3390/v16091446
BibTeX
@article{Demirchyan2024,
author = {Demirchyan, Anahit and Mozalevskis, Antons and Sahakyan, Serine and Musheghyan, Lusine and Aslanyan, Lusine and Muradyan, Diana and Sargsyants, Narina and Ghukasyan, Gayane and Petrosyan, Varduhi},
title = {Seroprevalence of Hepatitis C Virus and Factors Associated with It in Armenia, 2021},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16091446}
}
EUVIMED